Building Your Care Team and Preparing for Visits
At a Glance
Children with ITPR3-associated Immunodeficiency 133 need coordinated care led by a clinical immunologist, with genetics, neurology, dermatology, dentistry, and transplant specialists added as needed. Complete genetic, immune, and infection records help the team plan monitoring.
Because ITPR3-associated Immunodeficiency 133 is an ultra-rare multisystem condition, your child will need a team of specialists rather than a single doctor. The goal of this “care team” is not just to treat symptoms as they arise, but to proactively monitor your child’s health to prevent complications before they start [1][2].
The Core Specialist Roster
Your child’s care team should ideally be centered at a major academic medical center or a designated center for Inborn Errors of Immunity (IEI) [3][4].
- Clinical Immunologist (IEI Specialist): This is the most critical member of the team. They should have specific expertise in Combined Immunodeficiency (CID) and be familiar with T-cell development and signaling defects [5][6].
- Clinical Geneticist and Genetic Counselor: This specialist interprets the ITPR3 variant, explains the inheritance pattern (whether it is de novo or inherited based on parental testing), and provides counseling for the family [5][7].
- Neurologist and Rehabilitation Team: Since ITPR3 can cause peripheral neuropathy similar to Charcot-Marie-Tooth disease, a neurologist will monitor nerve function, strength, and gait through regular exams. (Nerve-conduction studies may be ordered if symptoms justify them, but a baseline study is not automatically appropriate for every child.) [8][9]
- Dermatologist and Pediatric Dentist: These specialists manage the ectodermal dysplasia features, such as skin integrity, sweat gland function, and dental enamel defects [5][10].
- Hematologist/Transplant Specialist: If your child’s immunodeficiency is severe or they are at high risk for EBV-associated HLH, a transplant specialist will evaluate the timing and risks of a Hematopoietic Stem Cell Transplant (HSCT) [11][12].
Vetting Your Specialists
When you first meet with a potential specialist, it is helpful to ask specific questions to gauge their experience with ultra-rare conditions like this one:
- “How many children with Combined Immunodeficiency do you currently manage in your practice?”
- “Are you familiar with the role of ITPR3 and calcium signaling in T-cell activation?”
- “What is your protocol for monitoring and responding to EBV (Epstein-Barr Virus) levels based on individualized labs in immunodeficient patients?” [11]
- “Can you coordinate with our other specialists to ensure that treatments for one system don’t negatively impact another?”
Preparing for Your First Consultation
Specialists in rare diseases rely heavily on the data collected by other doctors and by you as the parent. To make the most of your first visit, bring a comprehensive “Medical Passport” that includes:
- The Genetic Laboratory Report: Bring the full, multi-page report from the genetic testing company, not just a summary note. It must include the exact variant classification and the transcript version [5].
- Immunology Trends: Copies of all flow cytometry (lymphocyte subset) reports. It is most helpful for doctors to see how these numbers have changed over time [8][11].
- The Infection Log: A dated list of every infection your child has had, what germs were found (if any), and which medications worked [5].
- Neurology and Imaging: Reports from any prior neurology exams or clinical notes [8].
- Clinical Photographs: If your child has specific dental or skin features that change over time, bring dated photos to show the specialist [9].
Building this team takes time, but having a group of experts who are committed to “learning the disease” alongside you is the best way to ensure your child receives the highest level of care [3][13].
Common questions in this guide
Which specialists should be on my child’s care team for ITPR3-associated Immunodeficiency 133?
What records should I bring to my child’s first specialist visit?
How can I find the right immunologist for this rare condition?
How will my child be monitored for peripheral neuropathy?
When might my child need to see a transplant specialist?
How can I help the specialists coordinate my child’s care?
Get notified when new evidence is published on immunodeficiency 133 with ectodermal dysplasia with or without peripheral neuropathy.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
References
References (13)
- 1
Practice parameter for inborn errors of immunity: What is new in the 2025 update.
Chinen J, Horner CC, Orange JS
The Journal of allergy and clinical immunology 2026; (158(2)):368-373 doi:10.1016/j.jaci.2026.05.014.
PMID: 42208906 - 2
Severe Combined Immunodeficiency in the Newborn Period.
Salinas Cisneros G, Dvorak CC
NeoReviews 2025; (26(9)):e600-e614 doi:10.1542/neo.26-9-051.
PMID: 40887076 - 3
Growth in diagnosis and treatment of primary immunodeficiency within the global Jeffrey Modell Centers Network.
Quinn J, Modell V, Orange JS, Modell F
Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology 2022; (18(1)):19 doi:10.1186/s13223-022-00662-6.
PMID: 35246253 - 4
Inborn errors of immunity: manifestation, treatment, and outcome - an ESID registry 1994-2024 report on 30,628 patients.
Kindle G, Alligon M, Albert MH, et al.
medRxiv : the preprint server for health sciences 2025; doi:10.1101/2025.02.20.25322586.
PMID: 40568655 - 5
Dominant negative variants in ITPR3 impair T cell Ca2+ dynamics causing combined immunodeficiency.
Blanco E, Camps C, Bahal S, et al.
The Journal of experimental medicine 2025; (222(1)) doi:10.1084/jem.20220979.
PMID: 39560673 - 6
Disrupted Ca2+ homeostasis and immunodeficiency in patients with functional IP3 receptor subtype 3 defects.
Neumann J, Van Nieuwenhove E, Terry LE, et al.
Cellular & molecular immunology 2023; (20(1)):11-25 doi:10.1038/s41423-022-00928-4.
PMID: 36302985 - 7
Genetics of severe combined immunodeficiency.
Kumrah R, Vignesh P, Patra P, et al.
Genes & diseases 2020; (7(1)):52-61 doi:10.1016/j.gendis.2019.07.004.
PMID: 32181275 - 8
A pleiotropic recurrent dominant ITPR3 variant causes a complex multisystemic disease.
Molitor A, Lederle A, Radosavljevic M, et al.
Science advances 2024; (10(37)):eado5545 doi:10.1126/sciadv.ado5545.
PMID: 39270020 - 9
IP3 receptor depletion in a spontaneous canine model of Charcot-Marie-Tooth disease 1J with amelogenesis imperfecta.
Hytönen MK, Rönkkö J, Hundi S, et al.
PLoS genetics 2025; (21(1)):e1011328 doi:10.1371/journal.pgen.1011328.
PMID: 39804930 - 10
A Clinical Neurological Approach to the Child With Adenosine Deaminase Deficiency.
Ivarola P, Urdinez L, Oleastro M, et al.
Pediatric neurology 2024; (158()):49-56 doi:10.1016/j.pediatrneurol.2024.05.022.
PMID: 38959649 - 11
Two cases of combined immunodeficiency with ITPR3 mutations presenting with life-threatening severe EBV-associated hemophagocytic lymphohistiocytosis.
Yu L, Li Y, Zhang L, et al.
Frontiers in immunology 2025; (16()):1653662 doi:10.3389/fimmu.2025.1653662.
PMID: 41019080 - 12
Hematopoietic Stem Cell Transplantation in Primary Immunodeficiency Diseases: Current Status and Future Perspectives.
Castagnoli R, Delmonte OM, Calzoni E, Notarangelo LD
Frontiers in pediatrics 2019; (7()):295 doi:10.3389/fped.2019.00295.
PMID: 31440487 - 13
Jeffrey's Insights: Next-generation sequencing for primary immunodeficiency diagnosis, 2019-2025.
Quinn J, Fernández-Tabanera E, Perea-Romero I, et al.
Journal of human immunity 2027; (3(1)) doi:10.70962/jhi.20250192.
PMID: 42900003
This page is for informational purposes only and does not constitute medical advice. Your child's immunologist and care team should guide decisions about specialist referrals, testing, monitoring, and treatment.